Benzylamine
Suppliers
Names
[ CAS No. ]:
100-46-9
[ Name ]:
Benzylamine
[Synonym ]:
aminomethylbenzene
Phenylmethanamine
MFCD00212756
1-Phenylmethanamine
phenylmethanaminium
BENZYLAMIN, (ACIDIMETRISCH)
PHENYL-METHANAMINE
ω-Aminotoluene
benzyl amine
phenylmethylamine
BENZYLAMINE (100 ML )
α-Aminotoluene
Benzylamin
BENZYLAMINE FOR SYNTHESIS
EINECS 202-854-1
N-benzylamine
Benzenemethanamine
w-Aminotoluene
p-Aminomethylbenzene
Benzylamine
a-Aminotoluene
Chemical & Physical Properties
[ Density]:
1.0±0.1 g/cm3
[ Boiling Point ]:
185.0±0.0 °C at 760 mmHg
[ Melting Point ]:
-30 °C
[ Molecular Formula ]:
C7H9N
[ Molecular Weight ]:
107.153
[ Flash Point ]:
60.0±0.0 °C
[ Exact Mass ]:
107.073502
[ PSA ]:
26.02000
[ LogP ]:
1.09
[ Vapour Pressure ]:
0.7±0.3 mmHg at 25°C
[ Index of Refraction ]:
1.547
[ Stability ]:
Stability Combustible. Incompatible with strong oxidizing agents, strong acids.
[ Water Solubility ]:
soluble
MSDS
Toxicological Information
CHEMICAL IDENTIFICATION
- RTECS NUMBER :
- DP1488500
- CHEMICAL NAME :
- Benzylamine
- CAS REGISTRY NUMBER :
- 100-46-9
- BEILSTEIN REFERENCE NO. :
- 0741984
- LAST UPDATED :
- 199710
- DATA ITEMS CITED :
- 7
- MOLECULAR FORMULA :
- C7-H9-N
HEALTH HAZARD DATA
ACUTE TOXICITY DATA
- TYPE OF TEST :
- LD50 - Lethal dose, 50 percent kill
- ROUTE OF EXPOSURE :
- Intraperitoneal
- SPECIES OBSERVED :
- Rodent - mouse
- DOSE/DURATION :
- 600 mg/kg
- TOXIC EFFECTS :
- Details of toxic effects not reported other than lethal dose value
- REFERENCE :
- USXXAM United States Patent Document. (U.S. Patent Office, Box 9, Washington, DC 20231) Volume(issue)/page/year: #3816470
- TYPE OF TEST :
- LD50 - Lethal dose, 50 percent kill
- ROUTE OF EXPOSURE :
- Oral
- SPECIES OBSERVED :
- Mammal - species unspecified
- DOSE/DURATION :
- 700 mg/kg
- TOXIC EFFECTS :
- Details of toxic effects not reported other than lethal dose value
- REFERENCE :
- GISAAA Gigiena i Sanitariya. For English translation, see HYSAAV. (V/O Mezhdunarodnaya Kniga, 113095 Moscow, USSR) V.1- 1936- Volume(issue)/page/year: 39(4),86,1974 *** NIOSH STANDARDS DEVELOPMENT AND SURVEILLANCE DATA *** NIOSH OCCUPATIONAL EXPOSURE SURVEY DATA : NOHS - National Occupational Hazard Survey (1974) NOHS Hazard Code - M2937 No. of Facilities: 369 (estimated) No. of Industries: 7 No. of Occupations: 7 No. of Employees: 932 (estimated) NOES - National Occupational Exposure Survey (1983) NOES Hazard Code - M2937 No. of Facilities: 87 (estimated) No. of Industries: 3 No. of Occupations: 7 No. of Employees: 5721 (estimated) No. of Female Employees: 844 (estimated)
Safety Information
[ Symbol ]:
GHS05, GHS07
[ Signal Word ]:
Danger
[ Hazard Statements ]:
H302 + H312-H314
[ Precautionary Statements ]:
P301 + P312 + P330-P303 + P361 + P353-P304 + P340 + P310-P305 + P351 + P338
[ Personal Protective Equipment ]:
Faceshields;full-face respirator (US);Gloves;Goggles;multi-purpose combination respirator cartridge (US);type ABEK (EN14387) respirator filter
[ Hazard Codes ]:
C:Corrosive
[ Risk Phrases ]:
R21/22;R34
[ Safety Phrases ]:
S26-S36/37/39-S45
[ RIDADR ]:
UN 2735 8/PG 2
[ WGK Germany ]:
1
[ RTECS ]:
DP1488500
[ Packaging Group ]:
II
[ Hazard Class ]:
8
[ HS Code ]:
2921499090
Synthetic Route
Precursor & DownStream
Precursor
DownStream
Customs
[ HS Code ]: 2921499090
[ Summary ]:
2921499090 other aromatic monoamines and their derivatives; salts thereof VAT:17.0% Tax rebate rate:9.0% Supervision conditions:none MFN tariff:6.5% General tariff:30.0%
Articles
J. Med. Chem. 48 , 3269-79, (2005)
Growing interest in the use of both the logarithm of the partition coefficient of the neutral species in the alkane/water system (log P(N)(alk)) and the difference between log P(N)(oct) (the logarithm...
Anal. Chim. Acta 881 , 139-47, (2015)
A fast, simple, and sensitive flow injection analysis method was developed for the measurement of semicarbazide-sensitive amine oxidase (SSAO) activity in human serum. Benzaldehyde, generated by the a...
J. Clin. Invest. 125(2) , 501-20, (2015)
Nonalcoholic fatty liver disease (NAFLD) encompasses a range of manifestations, including steatosis and cirrhosis. Progressive disease is characterized by hepatic leukocyte accumulation in the form of...